SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-176587
Filing Date
2024-07-09
Accepted
2024-07-09 08:41:01
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-07-09

Document Format Files

Seq Description Document Type Size
1 ARS d861334dars.pdf ARS 850736
  Complete submission text file 0001193125-24-176587.txt   1173206
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38130 | Film No.: 241106409
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)